文献速递痛风与晶体性关节病

痛风与假性痛风相关晶体通过GLUT1介导的糖酵解调控巨噬细胞NLRP3与IL-1β活化

Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages.
PubMed 文献 · Ann Rheum Dis · 2020-07-22

该研究探讨了单钠尿酸盐(MSU)和焦磷酸钙(CPP)晶体刺激巨噬细胞后,糖酵解与氧化磷酸化在IL-1β诱导的微晶体反应中的作用。研究发现MSU和CPP晶体促使巨噬细胞代谢重编程为有氧糖酵解,表现为GLUT1质膜表达和葡萄糖摄取增加;葡萄糖剥夺、2-脱氧葡萄糖或GLUT1抑制剂均可抑制晶体诱导的NLRP3活化和IL-1β产生及体内微晶体炎症。结论提示GLUT1介导的葡萄糖摄取在MSU和CPP晶体诱导的IL-1β炎症反应中起关键作用。

要点

  • MSU和CPP晶体使巨噬细胞代谢转向有氧糖酵解,GLUT1表达和葡萄糖摄取增加。
  • 痛风发作时关节液中性粒细胞质膜GLUT1表达频率高于血中性粒细胞。
  • 葡萄糖剥夺、2-DG或GLUT1抑制剂可抑制晶体诱导的NLRP3活化、IL-1β产生及体内炎症。

核心结论

  • GLUT1介导的葡萄糖摄取在MSU和CPP晶体诱导的IL-1β炎症反应中起关键作用,为调控晶体相关炎症提供了新治疗方向。

研究设计与样本

  • 体外研究对MSU和CPP晶体刺激的巨噬细胞进行代谢组学和实时细胞外通量分析,以明确代谢表型。
  • 评估有氧糖酵解在IL-1β产生中的作用,采用体外和体内方法,包括18F-氟脱氧葡萄糖正电子发射断层成像、葡萄糖摄取实验及GLUT1抑制的分子手段。

主要发现

  • MSU和CPP晶体导致巨噬细胞代谢重编程为有氧糖酵解,表现为GLUT1质膜表达和葡萄糖摄取增加。
  • 痛风发作时人关节液分离的中性粒细胞比血中性粒细胞更频繁地在质膜表达GLUT1。
  • 葡萄糖剥夺、2-脱氧葡萄糖或GLUT1抑制剂均抑制晶体诱导的NLRP3活化和IL-1β产生,并抑制体内微晶体炎症。

临床怎么用

  • 靶向GLUT1介导的糖酵解可能成为调控痛风与假性痛风晶体相关炎症的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Macrophage activation by monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals mediates an interleukin (IL)-1β-dependent inflammation during gout and pseudo-gout flare, respectively. Since metabolic reprogramming of macrophages goes along with inflammatory responses dependently on stimuli and tissue environment, we aimed to decipher the role of glycolysis and oxidative phosphorylation in the IL-1β-induced microcrystal response. METHODS: Briefly, an in vitro study (metabolomics and real-time extracellular flux analysis) on MSU and CPP crystal-stimulated macrophages was performed to demonstrate the metabolic phenotype of macrophages. Then, the role of aerobic glycolysis in IL-1β production was evaluated, as well in vitro as in vivo using 18F-fluorodeoxyglucose positron emission tomography imaging and glucose uptake assay, and molecular approach of glucose transporter 1 (GLUT1) inhibition. RESULTS: We observed that MSU and CPP crystals led to a metabolic rewiring toward the aerobic glycolysis pathway explained by an increase in GLUT1 plasma membrane expression and glucose uptake on macrophages. Also, neutrophils isolated from human synovial fluid during gout flare expressed GLUT1 at their plasma membrane more frequently than neutrophils isolated from bloodstream. Both glucose deprivation and treatment with either 2-deoxyglucose or GLUT1 inhibitor suppressed crystal-induced NLRP3 activation and IL-1β production, and microcrystal inflammation in vivo. CONCLUSION: In conclusion, we demonstrated that GLUT1-mediated glucose uptake is instrumental during the inflammatory IL-1β response induced by MSU and CPP crystals. These findings open new therapeutic paths to modulate crystal-related inflammation.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Renaudin F, Orliaguet L, Castelli F, et al. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages. Ann Rheum Dis. 2020. PMID: 32699039. doi:10.1136/annrheumdis-2020-217342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。